TREA

79323815 - SEEGENE

Follow

Information

  • Trademark
  • 79323815
  • Serial Number
    79323815
  • Registration Number
    6966080
  • Filing Date
    July 06, 2021
    3 years ago
  • Registration Date
    January 31, 2023
    a year ago
  • Transaction Date
    May 30, 2023
    a year ago
  • Status Date
    January 31, 2023
    a year ago
  • Published for Opposition Date
    November 15, 2022
    2 years ago
  • Location Date
    January 31, 2023
    a year ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    KEELEY, ALISON REBECCA
  • Attorney Docket Number
    28193/64
    Attorney Name
    Max Vern
    Law Office Assigned Location Code
    M40
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
SEEGENE
Case File Statements
  • GS0441: Pharmaceutical advice; pharmacy advice in the field of preparation of prescriptions in pharmacies; providing medical information relating to diagnostic, prophylactic and therapeutic properties of medical products; providing medical information relating to diagnostic, prophylactic and therapeutic properties of medical products via the Internet; telemedicine services; medical services; medical information services provided via the Internet; medical and pharmaceutical consultation; medical testing services, namely, medical diagnostic testing; medical testing for diagnostic or treatment purposes; medical cancer testing for diagnostic or treatment purposes; genetic testing for medical purposes; healthcare services through the Internet; consulting services in the field of health management in the nature of managing health conditions through the internet; medical clinical pathology examination; health checkup and information services related thereto; medical clinical test in the nature of diagnostic testing and genetic testing for treatment purposes and information services related thereto; providing collected and managed medical information and personal health information; medical screening and examining services for disease prevention of cancer, infectious disease by pathogens and genetic disease by mutation; medical screening and examining services for disease prevention of cancer, infectious disease by pathogens and genetic disease by mutation to improve health culture; healthcare; health counselling; physical examination services; hospital services, not including dentistry services; medical clinic services, not including dentistry services; telemedicine services, not including dentistry services; rental of medical and health care equipment; medical assistance services; medical consultation services, not including dentistry services; medical equipment rental; providing health information services, not including dentistry services; health center services; performing diagnosis of diseases; medical and diagnostic services, namely, identifying hereditary risk factors; medical and medical diagnostic services for disease prevention; medical and diagnostic services, namely, diagnosing in the nature of in vitro diagnostic services for medical purposes; medical analysis services relating to the treatment of persons, namely, analysis of human bodily fluid and tissue samples for diagnostic and treatment services provided by a medical laboratory
  • GS0421: Research and development in the field of special testing using genetic engineering; biological services, namely, testing and analysis of biological samples in research laboratories; research and development of DNA chips; structural and functional analysis of genomes; biotechnological research; advisory services relating to biotechnological research; biological research; biochemical analysis; biochemical research; research in the field of gene analysis; genetic research; chemical analysis; research in the field of chemistry; chemical research and analysis; chemical research; research and development of vaccines and medicines; crude drugs research; research on adult diseases; bacteriological research; scientific research for medical purposes in the field of cancerous diseases; research relating to medicines; pharmaceutical products evaluation; consultancy pertaining to pharmacology; testing of pharmaceuticals; pharmaceutical research; medical research; medical science research in the field of clinical pathology and special examination; scientific research in the nature of conducting clinical trials for others; medical research and technical diagnostic testing services for evaluating clinical trial progress; medical research laboratory services for predicting disease; medical laboratory services, namely, preparation and analysis of human body tissue and fluid samples, providing reports respecting the same; research and development of infectious disease diagnosis products; research and development agency of infectious disease diagnosis products; research and development of bacterial and virus test products; research and development agency of bacterial and virus test products; research and development of genetic disease diagnosis products; research and development agency of genetic disease diagnosis products; research and development of blood analysis; research and development agency of blood analysis; research and development agency of cell test products for medical research, treatment, and diagnosis; research and development of cell test products for medical research, treatment, and diagnosis; research and development of body fluid and tissue sample analysis products for medical research, treatment, and diagnosis; research and development agency of body fluid and tissue sample analysis products for medical research, treatment, and diagnosis
Case File Event Statements
  • 5/30/2023 - a year ago
    26 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 5/4/2023 - a year ago
    25 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 5/4/2023 - a year ago
    24 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 4/30/2023 - a year ago
    23 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 1/31/2023 - a year ago
    22 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 1/31/2023 - a year ago
    21 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 11/15/2022 - 2 years ago
    20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 11/15/2022 - 2 years ago
    19 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 10/26/2022 - 2 years ago
    18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 10/10/2022 - 2 years ago
    17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 10/10/2022 - 2 years ago
    16 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 10/10/2022 - 2 years ago
    15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 10/10/2022 - 2 years ago
    14 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 10/10/2022 - 2 years ago
    13 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 9/10/2022 - 2 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/9/2022 - 2 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/9/2022 - 2 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 6/6/2022 - 2 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 5/16/2022 - 2 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 5/16/2022 - 2 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 4/1/2022 - 2 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 3/31/2022 - 2 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/25/2022 - 2 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 10/30/2021 - 3 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 10/26/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 10/22/2021 - 3 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR